The "Cannabis Extract Market Research Report by Product (Oils and Tinctures), Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Sep 20, 2022--
The Global Cannabis Extract Market size was estimated at USD 2,575.77 million in 2021, USD 3,030.85 million in 2022, and is projected to grow at a CAGR 17.84% to reach USD 6,898.78 million by 2027.
In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Cumulative Impact of COVID-19:
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.
It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cannabis Extract Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others.
Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.
Increasing legalization of medical cannabis across regions for easy access to patients
Growing use of marijuana for recreational and medical purposes
Rising adoption for the treatment of chronic diseases and mental diseases
Relatively high cost of the product
Burgeoning research and development investment for the application of cannabis across various industries
Ongoing taxation of the product to obtain more income for the government
Strict regulations in legalization of cannabis extract in several countries
Cumulative Impact of COVID-19
Market Segmentation & Coverage:
This research report categorizes the Cannabis Extract to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Oils and Tinctures.
Based on Type, the market was studied across Cannabis Isolates and Full Spectrum Extracts.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.
ABcann Medicinals, Inc.
Aphria, Inc
Aurora Cannabis Inc.
British American Tobacco PLC
Canopy Growth Corporation.
CBD American Shaman
Folium Biosciences
GW Pharmaceuticals, PLC By Jazz Pharmaceuticals
Indiva Limited
JULABO GmbH
Kynd Cannabis Company
Medical Marijuana, Inc.
Medicine Man Technologies, Inc
NuLeaf Naturals, LLC
Optimum Extracts
Organigram Holding, Inc.
Peridot Labs
PharmaHemp
The Cronos Group
Tikun Olam, Ltd. by Cannbit Pharmaceuticals
Tilray
VIVO Cannabis Inc
Wayland Group Corp.
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: CANNABIS NATURAL RESOURCES
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/20/2022 04:25 AM/DISC: 09/20/2022 04:26 AM
http://www.businesswire.com/news/home/20220920005666/en